ISEQ closes up 15.74 on bad day for Elan
Stocks at pharmaceutical company Elan fell by 38 cent to €16.52 today after the company reported increased costs and decreased revenues for the second quarter of 2004.
Elan said total revenue for the period was down 45% to $116.2m (€96.3m).





